![Global Non-Invasive Prenatal Testing (NIPT) Market](https://res.cloudinary.com/devmoveo/image/upload/v1675695199/skyquest/gallery/Global-Non-Invasive-Prenatal-Testing-%28nipt%29-Market.jpg)
Report ID: SQMIG35J2080
Report ID:
SQMIG35J2080 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|
Tables:
63 |
Figures:
75
North America dominated the global Non-Invasive Prenatal Testing (NIPT) market in 2021. This is a result of both the rising incidence of Down syndrome in babies and the growing use of noninvasive prenatal diagnostics. Furthermore, the expanding use of these exams in the US and Canada has been greatly influenced by players with a significant geographic presence in the US who provide advanced assessments. The Panorama test, created by Natera, is the only one that can distinguish between maternal and foetal DNA in the target chromosomes. It uses single-nucleotide polymorphism (SNP)-based technology to analyse DNA. In the following years, such innovative advancements are projected to increase usage and fuel market expansion in this region.
The market in Asia Pacific is anticipated to grow more rapidly than other regions. Early detection of chromosomal problems during pregnancy is becoming more and more popular in developing countries like China and India. It is anticipated that this will lead to the introduction of new goods and tests, along with domestic market participants stressing strategies like alliances and collaborations with international businesses.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG35J2080